Computime Group Limited announced that Mr. WONG Samuel Wan Kay ("Mr. WONG") has resigned as the company secretary of the Company (the "Company Secretary") and ceased to act as the authorized representative of the Company as required under Rule 3.05 of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (the "Stock Exchange") and the authorized representative for accepting service of process or notices on behalf of the Company in Hong Kong under the Companies Ordinance (Chapter 622, Laws of Hong Kong) (the "Authorised Representatives") with effect from 3 January 2024. The Board further announces that Mr. CHUNG Ming Kit ("Mr. CHUNG") has been appointed as the Company Secretary and the Authorised Representatives with effect from 3 January 2024. Mr. CHUNG, aged 46, joined the Group in 2022 as chief financial officer of the Group.

He has over 20 years of experience in finance, accounting and management. Prior to joining Group, he had worked in an international accounting firm and other companies listed on the Main Board of the Stock Exchange, NASDAQ and the Singapore Exchange Limited. Mr. CHUNG obtained his Bachelor degree in business administration in accounting from the Hong Kong University of Science and Technology in Hong Kong.

He is a holder of a Chartered Financial Analyst of the CFA Institute and a fellow member of the Hong Kong Institute of Certified Public Accountants. Mr. CHUNG is an independent non-executive director of Cutia Therapeutics, a company listed on the Stock Exchange.